Capital Financial Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$868K Sell
4,915
-50
-1% -$8.63K 1.2% 31
2022
Q3
$811K Hold
4,965
1.2% 30
2022
Q2
$881K Hold
4,965
1.24% 33
2022
Q1
$880K Hold
4,965
1.04% 34
2021
Q4
$849K Hold
4,965
0.93% 38
2021
Q3
$802K Buy
4,965
+30
+0.6% +$5.12K 0.98% 38
2021
Q2
$813K Sell
4,935
-240
-5% -$39.7K 1.03% 34
2021
Q1
$851K Buy
5,175
+40
+0.8% +$6.47K 1.14% 31
2020
Q4
$808K Buy
+5,135
New +$758K 1.13% 31

Other funds holding JNJ

Capital Financial Services's JNJ Position: Q4 2022 in Review

Capital Financial Services reduced its Johnson & Johnson (JNJ) stake by 1% in Q4 2022, selling an estimated $8.63K and leaving 4,915 shares worth $868K. The position accounts for 1.2% of the portfolio, ranked #31.

Capital Financial Services first reported a position in JNJ in Q4 2020 and has held it in 9 quarters since. The position peaked at $881K in Q2 2022. 3,788 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Capital Financial Services held 4,915 shares of Johnson & Johnson worth $868K as of Q4 2022.
  • Capital Financial Services sold 50 Johnson & Johnson shares in Q4 2022, an estimated $8.63K.
  • Johnson & Johnson made up 1.2% of Capital Financial Services's portfolio in Q4 2022, its #31 holding.
  • Capital Financial Services first reported a position in Johnson & Johnson in Q4 2020 and has held it in 9 quarters since.
  • Capital Financial Services's Johnson & Johnson position peaked at $881K in Q2 2022.
  • 3,788 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Capital Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.